Federal grants to Therapyx, Inc.
Therapyx, Inc. in Buffalo, New York received $11.2 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Allergy and Infectious Diseases Research, with $7.2 million. In fiscal 2025 it was awarded $2.0 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$11.2 million
- Awards5
- Awarded in FY 2025$2.0 million
- Largest award$4.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $2.8 million |
| FY 2022 | 3 | $2.2 million |
| FY 2023 | 2 | $2.2 million |
| FY 2024 | 2 | $2.0 million |
| FY 2025 | 2 | $2.0 million |
Programs that fund Therapyx, Inc.
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 4 | $7.2 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $4.0 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 5 | $11.2 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| IL-10NANOCAP? For therapy of familial adenomatous polyposis | Diabetes, Digestive, and Kidney Diseases Extramural Research | March 8, 2021 | $4.0 million |
| Therapy and prophylaxis for genital tract infection - abstract GNEX12 is a patented therapeutic vaccine in development specifically for women with neisseria gonorrhoeae (gonorrhea) infection. It is a novel formulation of recombinant human INTERLEUKIN-12 (IL-12) encapsulated in biodegradable sustaine | Allergy and Infectious Diseases Research | August 21, 2023 | $3.0 million |
| Experimental gonococcal vaccine | Allergy and Infectious Diseases Research | June 29, 2021 | $2.0 million |
| Therapy and prophylaxis for genital tract infection | Allergy and Infectious Diseases Research | April 23, 2021 | $1.9 million |
| Omv vaccine against gonorrhea - abstract gonorrhea is a genital tract infection caused by neisseria gonorrhoeae, which can be acquired repeatedly and does not naturally induce a state of specific protective immunity against reinfection. Despite public health measures, gonorrhea persists at an unacce | Allergy and Infectious Diseases Research | February 22, 2022 | $300,000 |
Questions people ask
How much federal grant money does Therapyx, Inc. get?
$11.2 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Therapyx, Inc. the most?
The Department of Health and Human Services, with $11.2 million in 5 awards.
What is Therapyx, Inc.'s largest federal grant?
$4.0 million under Diabetes, Digestive, and Kidney Diseases Extramural Research, with its first action in the period on March 8, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Therapyx, Inc.?
Its largest are Allergy and Infectious Diseases Research and Diabetes, Digestive, and Kidney Diseases Extramural Research.
Other grant recipients in Buffalo
- The Research Foundation for the State University of New York
- Niagara Frontier Transportation Authority
- Health Research, Inc.
- Buffalo Municipal Housing Auth
- City of Buffalo
- The Community Action Organization of Western New York, Inc.
- University at Buffalo
- The Research Foundation for the State University of New York
Largest federal grant recipients in New York · Federal grants in New York